Diabetes and change in bone mineral density at the hip, calcaneus, spine, and radius in older women

Frontiers in Endocrinology

Volumn 4, Issue MAY, 2013, Pages

  Schwartz, Ann V ^a   Ewing, Susan K ^a   Porzig, Anne M ^a   McCulloch, Charles E ^a   Resnick, Helaine E ^b   Hillier, Teresa A ^c   Ensrud, Kristine E ^d   Black, Dennis M ^a   Nevitt, Michael C ^a   Cummings, Steven R ^e   Sellmeyer, Deborah E ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c CENTER FOR HEALTH RESEARCH   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone mineral density; Longitudinal studies; Older adults; Type 2 diabetes mellitus; Women

Indexed keywords

AGED; AGING; BODY WEIGHT; BONE DENSITY; CALCANEUS; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; FRAGILITY FRACTURE; GAIT; GRIP STRENGTH; HIP; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; NERVE FUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOLYSIS; PHOTON ABSORPTIOMETRY; PROSPECTIVE STUDY; RADIOULNAR JOINT; RADIUS; REVIEW; SPINE;

EID: 84884190712     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2013.00062     Document Type: Review

References (47)

1. Ahmed, L. A., Emaus, N., Berntsen, G. K., Bjornerem, A., Fonnebo, V., Jorgensen, L., et al. (2010). Bone loss and the risk of non-vertebral fractures in women and men: the Tromso study. Osteoporos. Int. 21, 1503-1511. doi:10.1007/s00198-009-1102-z
2. Bauer, D. C., Browner, W. S., Cauley, J. A., Orwoll, E. S., Scott, J. C., Black, D. M., et al. (1993). Factors associated with appendicular bone mass in older women. The Study of Osteoporotic Fractures Research Group. Ann. Intern. Med. 118, 657-665. doi:10.7326/0003-4819-118-9-199305010-00001
3. Berberoglu, Z., Gursoy, A., Bayraktar, N., Yazici, A. C., Tutuncu, N. B., and Demirag, N. G. (2007). Rosiglitazone decreases serum bone-specific alkaline phosphatase activity in postmenopausal diabetic women. J. Clin. Endocrinol. Metab. 92, 3523-3530. doi:10.1210/jc.2007-0431
4. Berger, C., Langsetmo, L., Joseph, L., Hanley, D. A., Davison, K. S., Josse, R. G., et al. (2009). Association between change in BMD and fragility fracture in women and men. J. Bone Miner. Res. 24, 361-370. doi:10.1359/jbmr.081004
5. Borges, J. L., Bilezikian, J. P., Jones-Leone, A. R., Acusta, A. P., Ambery, P. D., Nino, A. J., et al. (2011). A randomized, parallel group, double-blind, multicentre study comparing the efficacy and safety of Avandamet (rosiglitazone/metformin) and metformin on long-term glycaemic control and bone mineral density after 80 weeks of treatment in drug-naive type 2 diabetes mellitus patients. Diabetes Obes. Metab. 13, 1036-1046.
6. Bruyere, O., Roux, C., Detilleux, J., Slosman, D. O., Spector, T. D., Fardellone, P., et al. (2007). Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate. J. Clin. Endocrinol. Metab. 92, 3076-3081. doi:10.1210/jc.2006-2758
7. Buysschaert, M., Cauwe, F., Jamart, J., Brichant, C., De Coster, P., Magnan, A., et al. (1992). Proximal femur density in type 1 and 2 diabetic patients. Diabete Metab. 18, 32-37.
8. Cauley, J. A., Danielson, M. E., Boudreau, R. M., Forrest, K. Y., Zmuda, J. M., Pahor, M., et al. (2007). Inflammatory markers and incident fracture risk in older men and women: the Health Aging and Body Composition Study. J. Bone Miner. Res. 22, 1088-1095. doi:10.1359/jbmr.070409
9. Cauley, J. A., Lui, L. Y., Barnes, D., Ensrud, K. E., Zmuda, J. M., Hillier, T. A., et al. (2009). Successful skeletal aging: a marker of low fracture risk and longevity. The Study of Osteoporotic Fractures (SOF). J. Bone Miner. Res. 24, 134-143. doi:10.1359/jbmr.080813
10. Cawthon, P. M., Ewing, S. K., Mackey, D. C., Fink, H. A., Cummings, S. R., Ensrud, K. E., et al. (2012). Change in hip bone mineral density and risk of subsequent fractures in older men. J. Bone Miner. Res. 27, 2179-2188. doi:10.1002/jbmr.1671
11. Clowes, J. A., Riggs, B. L., and Khosla, S. (2005). The role of the immune system in the pathophysiology of osteoporosis. Immunol. Rev. 208, 207-227. doi:10.1111/j.0105-2896.2005.00334.x
12. Cowie, C. C., Rust, K. F., Ford, E. S., Eberhardt, M. S., Byrd-Holt, D. D., Li, C., et al. (2009). Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 32, 287-294. doi:10.2337/dc08-1296 CrossRef Full Text
13. Cummings, S. R., Black, D. M., Nevitt, M. C., Browner, W. S., Cauley, J. A., Genant, H. K., et al. (1990). Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group. JAMA 263, 665-668. doi:10.1001/jama.1990.03440050059033
14. Cummings, S. R., Nevitt, M. C., Browner, W. S., Stone, K., Fox, K. M., Ensrud, K. E., et al. (1995). Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N. Engl. J. Med. 332, 767-773. doi:10.1056/NEJM199503233321202
15. Ensrud, K. E., Ewing, S. K., Stone, K. L., Cauley, J. A., Bowman, P. J., and Cummings, S. R. (2003). Intentional and unintentional weight loss increase bone loss and hip fracture risk in older women. J. Am. Geriatr. Soc. 51, 1740-1747. doi:10.1046/j.1532-5415.2003.51558.x
16. Garcia-Martin, A., Rozas-Moreno, P., Reyes-Garcia, R., Morales-Santana, S., Garcia-Fontana, B., Garcia-Salcedo, J. A., et al. (2012). Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 97, 234-241. doi:10.1210/jc.2011-2186
17. Giangregorio, L. M., Leslie, W. D., Lix, L. M., Johansson, H., Oden, A., McCloskey, E., et al. (2012). FRAX underestimates fracture risk in patients with diabetes. J. Bone Miner. Res. 27, 301-308. doi:10.1002/jbmr.556
18. Greendale, G. A., Barrett-Connor, E., Edelstein, S., Ingles, S., and Haile, R. (1995). Lifetime leisure exercise and osteoporosis. The Rancho Bernardo study. Am. J. Epidemiol. 141, 951-959.
19. Grey, A. (2008). Skeletal consequences of thiazolidinedione therapy. Osteoporos. Int. 19, 129-137. doi:10.1007/s00198-007-0477-y
20. Gullberg, B., Johnell, O., and Kanis, J. A. (1997). World-wide projections for hip fracture. Osteoporos. Int. 7, 407-413. doi:10.1007/PL00004148
21. Hannan, M. T., Felson, D. T., Dawson-Hughes, B., Tucker, K. L., Cupples, L. A., Wilson, P. W., et al. (2000). Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. J. Bone Miner. Res. 15, 710-720. doi:10.1359/jbmr.2000.15.4.710
22. Hillier, T. A., Stone, K. L., Bauer, D. C., Rizzo, J. H., Pedula, K. L., Cauley, J. A., et al. (2007). Evaluating the value of repeat bone mineral density measurement and prediction of fractures in older women: the study of osteoporotic fractures. Arch. Intern. Med. 167, 155-160. doi:10.1001/archinte.167.2.155
23. Ishii, S., Cauley, J. A., Crandall, C. J., Srikanthan, P., Greendale, G. A., Huang, M. H., et al. (2012). Diabetes and femoral neck strength: findings from the hip strength across the menopausal transition study. J. Clin. Endocrinol. Metab. 97, 190-197. doi:10.1210/jc.2011-1883
24. Janghorbani, M., Van Dam, R. M., Willett, W. C., and Hu, F. B. (2007). Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am. J. Epidemiol. 166, 495-505. doi:10.1093/aje/kwm106
25. Keegan, T. H., Schwartz, A. V., Bauer, D. C., Sellmeyer, D. E., and Kelsey, J. L. (2004). Effect of alendronate on bone mineral density and biochemical markers of bone turnover in type 2 diabetic women: the fracture intervention trial. Diabetes Care 27, 1547-1553. doi:10.2337/diacare.27.7.1547
26. Khalil, N., Sutton-Tyrrell, K., Strotmeyer, E. S., Greendale, G. A., Vuga, M., Selzer, F., et al. (2011). Menopausal bone changes and incident fractures in diabetic women: a cohort study. Osteoporos. Int. 22, 1367-1376. doi:10.1007/s00198-010-1357-4
27. Krakauer, J. C., McKenna, M. J., Buderer, N. F., Rao, D. S., Whitehouse, F. W., and Parfitt, A. M. (1995). Bone loss and bone turnover in diabetes. Diabetes 44, 775- 782. doi:10.2337/diabetes.44.7.775
28. Looker, H. C., Knowler, W. C., and Hanson, R. L. (2001). Changes in BMI and weight before and after the development of type 2 diabetes. Diabetes Care 24, 1917- 1922. doi:10.2337/diacare.24.11.1917
29. Ma, L., Oei, L., Jiang, L., Estrada, K., Chen, H., Wang, Z., et al. (2012). Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies. Eur. J. Epidemiol. 27, 319-332. doi:10.1007/s10654-012-9674-x
30. Manolagas, S. C., and Almeida, M. (2007). Gone with the Wnts: {beta}-catenin, TCF, FOXO, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism. Mol. Endocrinol. 21, 2605-2614. doi:10.1210/me.2007-0259
31. Melton, L. J. III, Riggs, B. L., Leibson, C. L., Achenbach, S. J., Camp, J. J., Bouxsein, M. L., et al. (2008). A bone structural basis for fracture risk in diabetes. J. Clin. Endocrinol. Metab. 93, 4804-4809. doi:10.1210/jc.2008-0639
32. Moritz, D. J., Ostfeld, A. M., Blazer, D., Curb, D., Taylor, J. O., and Wallace, R. B. (1994). The health burden of diabetes for the elderly in four communities. Public Health Rep. 109, 782-790.
33. Nguyen, T. V., Center, J. R., and Eisman, J. A. (2005). Femoral neck bone loss predicts fracture risk independent of baseline BMD. J. Bone Miner. Res. 20, 1195- 1201. doi:10.1359/JBMR.050215
34. Orwoll, E. S., Bauer, D. C., Vogt, T. M., and Fox, K. M. (1996). Axial bone mass in older women. Study of Osteoporotic Fractures Research Group. Ann. Intern. Med. 124, 187-196. doi:10.7326/0003-4819-124-2-199601150-00001
35. Patsch, J. M., Burghardt, A. J., Yap, S. P., Baum, T., Schwartz, A. V., Joseph, G. B., et al. (2013). Increased cortical porosity in type 2 diabetic postmenopausal women with fragility fractures. J. Bone Miner. Res. 28, 313-324. doi:10.1002/jbmr.1763
36. Petit, M., Paudel, M. L., Taylor, B., Hughes, J., Strotmeyer, E. S., Schwartz, A. V., et al. (2010). Bone mass and strength in older men with type 2 diabetes: the Osteoporotic Fractures in Men Study. J. Bone Miner. Res. 25, 285-291. doi:10.1359/jbmr.090725
37. Raskin, P., Stevenson, M. R., Barilla, D. E., and Pak, C. Y. (1978). The hypercalciuria of diabetes mellitus: its amelioration with insulin. Clin. Endocrinol. (Oxf.) 9, 329 -335. doi:10.1111/j.1365-2265.1978.tb02218.x
38. Schneider, A. L., Pankow, J. S., Heiss, G., and Selvin, E. (2012). Validity and reliability of self-reported diabetes in the atherosclerosis risk in communities study. Am. J. Epidemiol. 176, 738-743. doi:10.1093/aje/kws156
39. Schwartz, A. V., Garnero, P., Hillier, T. A., Sellmeyer, D. E., Strotmeyer, E. S., Feingold, K. R., et al. (2009). Pentosidine and increased fracture risk in older adults with type 2 diabetes. J. Clin. Endocrinol. Metab. 94, 2380-2386. doi:10.1210/jc.2008-2498
40. Schwartz, A. V., Sellmeyer, D. E., Strotmeyer, E. S., Tylavsky, F. A., Feingold, K. R., Resnick, H. E., et al. (2005). Diabetes and bone loss at the hip in older black and white adults. J. Bone Miner. Res. 20, 596-603. doi:10.1359/JBMR.041219
41. Schwartz, A. V., Vittinghoff, E., Bauer, D. C., Hillier, T. A., Strotmeyer, E. S., Ensrud, K. E., et al. (2011). Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA 305, 2184-2192. doi:10.1001/jama.2011.715
42. Seeley, D. G., Cauley, J. A., Grady, D., Browner, W. S., Nevitt, M. C., and Cummings, S. R. (1995). Is postmenopausal estrogen therapy associated with neuromuscular function or falling in elderly women? Study of Osteoporotic Fractures Research Group. Arch. Intern. Med. 155, 293-299. doi:10.1001/archinte.1995.00430030087010
43. Shu, A., Yin, M. T., Stein, E., Cremers, S., Dworakowski, E., Ives, R., et al. (2012). Bone structure and turnover in type 2 diabetes mellitus. Osteoporos. Int. 23, 635- 641. doi:10.1007/s00198-011-1595-0
44. Sornay-Rendu, E., Munoz, F., Duboeuf, F., and Delmas, P. D. (2005). Rate of forearm bone loss is associated with an increased risk of fracture independently of bone mass in postmenopausal women: the OFELY study. J. Bone Miner. Res. 20, 1929-1935. doi:10.1359/JBMR.050704
45. Vestergaard, P. (2007). Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis. Osteoporos. Int. 18, 427- 444. doi:10.1007/s00198-006-0253-4
46. Vogt, M. T., Cauley, J. A., Kuller, L. H., and Nevitt, M. C. (1997). Bone mineral density and blood flow to the lower extremities: the study of osteoporotic fractures. J. Bone Miner. Res. 12, 283-289. doi:10.1359/jbmr.1997.12.2.283
47. Wild, S., Roglic, G., Green, A., Sicree, R., and King, H. (2004). Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047-1053. doi:10.2337/diacare.27.10.2569-a